INVO Fertility (IVF) Competitors $1.46 +0.04 (+2.82%) As of 06/11/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsSEC FilingsTrendsBuy This Stock IVF vs. VVOS, BTCY, WOK, INBS, PAVM, DHAI, MHUA, SSKN, CODX, and NUROShould you be buying INVO Fertility stock or one of its competitors? The main competitors of INVO Fertility include Vivos Therapeutics (VVOS), Biotricity (BTCY), WORK Medical Technology Group LTD Ordinary Shares (WOK), Intelligent Bio Solutions (INBS), PAVmed (PAVM), DIH Holding US (DHAI), Meihua International Medical Technologies (MHUA), STRATA Skin Sciences (SSKN), Co-Diagnostics (CODX), and NeuroMetrix (NURO). These companies are all part of the "medical equipment" industry. INVO Fertility vs. Its Competitors Vivos Therapeutics Biotricity WORK Medical Technology Group LTD Ordinary Shares Intelligent Bio Solutions PAVmed DIH Holding US Meihua International Medical Technologies STRATA Skin Sciences Co-Diagnostics NeuroMetrix Vivos Therapeutics (NASDAQ:VVOS) and INVO Fertility (NASDAQ:IVF) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability, valuation and community ranking. Which has more risk & volatility, VVOS or IVF? Vivos Therapeutics has a beta of 7.02, indicating that its stock price is 602% more volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.23, indicating that its stock price is 123% more volatile than the S&P 500. Does the MarketBeat Community prefer VVOS or IVF? Vivos Therapeutics received 17 more outperform votes than INVO Fertility when rated by MarketBeat users. Likewise, 53.13% of users gave Vivos Therapeutics an outperform vote while only 0.00% of users gave INVO Fertility an outperform vote. CompanyUnderperformOutperformVivos TherapeuticsOutperform Votes1753.13% Underperform Votes1546.88% INVO FertilityOutperform VotesNo VotesUnderperform Votes1100.00% Do institutionals & insiders have more ownership in VVOS or IVF? 26.4% of Vivos Therapeutics shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 3.0% of Vivos Therapeutics shares are owned by company insiders. Comparatively, 1.8% of INVO Fertility shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is VVOS or IVF more profitable? INVO Fertility has a net margin of 0.00% compared to Vivos Therapeutics' net margin of -86.19%. INVO Fertility's return on equity of 0.00% beat Vivos Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Vivos Therapeutics-86.19% -335.04% -93.58% INVO Fertility N/A N/A N/A Do analysts prefer VVOS or IVF? Vivos Therapeutics currently has a consensus price target of $4.82, suggesting a potential upside of 116.97%. Given Vivos Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Vivos Therapeutics is more favorable than INVO Fertility.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivos Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50INVO Fertility 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to VVOS or IVF? In the previous week, Vivos Therapeutics had 3 more articles in the media than INVO Fertility. MarketBeat recorded 4 mentions for Vivos Therapeutics and 1 mentions for INVO Fertility. INVO Fertility's average media sentiment score of 1.87 beat Vivos Therapeutics' score of 0.57 indicating that INVO Fertility is being referred to more favorably in the news media. Company Overall Sentiment Vivos Therapeutics Positive INVO Fertility Very Positive Which has preferable earnings and valuation, VVOS or IVF? Vivos Therapeutics has higher revenue and earnings than INVO Fertility. Vivos Therapeutics is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVivos Therapeutics$14.63M0.89-$13.58M-$1.73-1.28INVO Fertility$6.59M0.48-$73.60M-$34.06-0.04 SummaryVivos Therapeutics beats INVO Fertility on 13 of the 18 factors compared between the two stocks. Get INVO Fertility News Delivered to You Automatically Sign up to receive the latest news and ratings for IVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IVF vs. The Competition Export to ExcelMetricINVO FertilitySurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$3.16M$352.50M$2.03B$8.63BDividend YieldN/AN/A2.60%4.18%P/E Ratio-0.04N/A22.6220.06Price / Sales0.4810.7455.42157.10Price / CashN/AN/A51.7234.64Price / BookN/AN/A2.084.70Net Income-$73.60MN/A-$292.00M$247.88M7 Day Performance-2.01%4.34%1.46%2.63%1 Month PerformanceN/A-0.32%13.86%6.36%1 Year PerformanceN/AN/A18.05%14.05% INVO Fertility Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IVFINVO FertilityN/A$1.46+2.8%N/AN/A$3.16M$6.59M-0.0410VVOSVivos Therapeutics1.5913 of 5 stars$2.14-4.0%$4.82+125.1%-11.2%$12.61M$14.63M-0.38160News CoverageShort Interest ↑BTCYBiotricityN/A$0.50-4.8%N/A-48.5%$12.46M$12.06M-0.4640Gap DownHigh Trading VolumeWOKWORK Medical Technology Group LTD Ordinary SharesN/A$0.82-2.4%N/AN/A$12.26M$11.51M0.00226Positive NewsINBSIntelligent Bio Solutions0.3933 of 5 stars$1.70+2.4%N/A+0.0%$11.75M$2.94M0.0010News CoveragePositive NewsPAVMPAVmed3.8026 of 5 stars$0.64+1.6%$19.00+2,858.6%-40.5%$10.98M$1.99M-0.1590DHAIDIH Holding US0.985 of 5 stars$0.22+1.3%N/A-89.9%$10.52M$64.47M-0.74N/APositive NewsGap UpMHUAMeihua International Medical Technologies1.7293 of 5 stars$0.42-30.6%N/A-46.3%$10.42M$96.91M0.00620Short Interest ↓SSKNSTRATA Skin Sciences2.8373 of 5 stars$2.41-1.0%$6.00+149.5%-22.4%$10.03M$33.62M-0.90120Short Interest ↑Gap UpCODXCo-Diagnostics4.1577 of 5 stars$0.30-0.7%$5.50+1,745.0%-80.8%$10.01M$3.71M-0.22100Short Interest ↑NURONeuroMetrixN/A$4.55+4.4%N/A+19.7%$9.37M$3.03M-0.9920High Trading Volume Related Companies and Tools Related Companies Vivos Therapeutics Alternatives Biotricity Alternatives WORK Medical Technology Group LTD Ordinary Shares Alternatives Intelligent Bio Solutions Alternatives PAVmed Alternatives DIH Holding US Alternatives Meihua International Medical Technologies Alternatives STRATA Skin Sciences Alternatives Co-Diagnostics Alternatives NeuroMetrix Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IVF) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Fertility, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Fertility With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
